KIM-1’s independent association with long-term graft loss [21,22] and its dual role as a marker for both acute kidney injury (AKI) and chronic kidney disease (CKD) [23] emphasize the need for careful interpretation of its levels in diverse clinical scenarios. This evidence concerns the gene HAVCR1 and chronic kidney disease.